Local VEGF‐A blockade modulates the microenvironment of the corneal graft bed
暂无分享,去创建一个
C. Cursiefen | R. Reuten | M. Koch | F. Bock | E. Mahabir | Ann-Charlott Salabarria | Malte Heykants | G. Braun | Gabriele Braun
[1] J. Horstmann,et al. UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high‐risk corneal transplant survival , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] C. Cursiefen,et al. Fine Needle-Diathermy Regresses Pathological Corneal (Lymph)Angiogenesis and Promotes High-Risk Corneal Transplant Survival , 2018, Scientific Reports.
[3] A. Gilman‐Sachs,et al. Early pregnancy immune biomarkers in peripheral blood may predict preeclampsia. , 2018, Journal of reproductive immunology.
[4] R. Dana,et al. Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation , 2017, Scientific Reports.
[5] Trushar R. Patel,et al. Structural decoding of netrin-4 reveals a regulatory function towards mature basement membranes , 2016, Nature Communications.
[6] R. Dana,et al. Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis , 2016, Investigative ophthalmology & visual science.
[7] S. Jalkanen,et al. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer , 2015, Oncoimmunology.
[8] S. Govoni,et al. Targeting VEGF in eye neovascularization: What's new?: A comprehensive review on current therapies and oligonucleotide-based interventions under development. , 2016, Pharmacological research.
[9] R. Dana,et al. VEGF-trap Aflibercept Significantly Improves Long-term Graft Survival in High-risk Corneal Transplantation , 2015, Transplantation.
[10] G. Han,et al. Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection. , 2015, International journal of clinical and experimental medicine.
[11] C. Cursiefen,et al. Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye? , 2015, Seminars in cell & developmental biology.
[12] R. Dana,et al. Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity , 2014, Journal of clinical & cellular immunology.
[13] D. Meller,et al. Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study. , 2014, Ophthalmology.
[14] U. Schraermeyer,et al. Effects of a Single Intravitreal Injection of Aflibercept and Ranibizumab on Glomeruli of Monkeys , 2014, PloS one.
[15] C. Cursiefen,et al. Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.
[16] E. Tartour,et al. Control of the Immune Response by Pro-Angiogenic Factors , 2014, Front. Oncol..
[17] C. Cursiefen,et al. Topical Ranibizumab inhibits inflammatory corneal hem‐ and lymphangiogenesis , 2014, Acta ophthalmologica.
[18] P. Hamrah,et al. Corneal Allograft Rejection: Immunopathogenesis to Therapeutics , 2013, Journal of clinical & cellular immunology.
[19] R. González-Amaro,et al. CCL22-Producing CD8α− Myeloid Dendritic Cells Mediate Regulatory T Cell Recruitment in Response to G-CSF Treatment , 2013, The Journal of Immunology.
[20] L. Boon,et al. Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival , 2013, The Journal of Immunology.
[21] P. Berggren,et al. Role of T Cell Recruitment and Chemokine‐Regulated Intra‐Graft T Cell Motility Patterns in Corneal Allograft Rejection , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] A. Teixeira-Carvalho,et al. Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. , 2013, Cytokine.
[23] M. Sade-Feldman,et al. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. , 2013, Immunity.
[24] J. Niederkorn. Corneal Transplantation and Immune Privilege , 2013, International reviews of immunology.
[25] F. Kruse,et al. Angioregressive Pretreatment of Mature Corneal Blood Vessels Before Keratoplasty: Fine-Needle Vessel Coagulation Combined With Anti-VEGFs , 2012, Cornea.
[26] M. Sade-Feldman,et al. New insights into chronic inflammation-induced immunosuppression. , 2012, Seminars in cancer biology.
[27] N. Mukaida,et al. Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization. , 2012, Investigative ophthalmology & visual science.
[28] G. Yancopoulos,et al. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab , 2012, Angiogenesis.
[29] D. Schadendorf,et al. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model , 2011, Proceedings of the National Academy of Sciences.
[30] Peter W. Chen,et al. IL-17A–Dependent CD4+CD25+ Regulatory T Cells Promote Immune Privilege of Corneal Allografts , 2011, The Journal of Immunology.
[31] J. Niederkorn,et al. High-risk corneal allografts and why they lose their immune privilege , 2010, Current opinion in allergy and clinical immunology.
[32] Claus Cursiefen,et al. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. , 2010, Ophthalmology.
[33] D. Azar,et al. VEGF TrapR1R2 Suppresses Experimental Corneal Angiogenesis , 2010, European journal of ophthalmology.
[34] S. Wiegand,et al. Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation , 2009, The Journal of Immunology.
[35] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[36] R. Dana,et al. Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation , 2009, British Journal of Ophthalmology.
[37] R. Dana,et al. Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation1 , 2009, The Journal of Immunology.
[38] F. Horn,et al. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. , 2008, Experimental eye research.
[39] Y. Belkaid,et al. Review Tuning Microenvironments: Induction of Regulatory T Cells by Dendritic Cells Induction of Foxp3 + Treg Cells by Dcs , 2022 .
[40] K. Maruyama,et al. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. , 2008, Archives of ophthalmology.
[41] H. Volk,et al. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival. , 2007, Transplant immunology.
[42] Björn Bachmann,et al. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. , 2007, Investigative ophthalmology & visual science.
[43] D. Dix,et al. Inhibition of Corneal Angiogenesis by Topical Administration of VEGF Trap , 2007 .
[44] J. Niederkorn. Immune Mechanisms of Corneal Allograft Rejection , 2007, Current eye research.
[45] Flora Zavala,et al. Granulocyte Colony-Stimulating Factor: A Novel Mediator of T Cell Tolerance1 , 2005, The Journal of Immunology.
[46] M. Dana,et al. Early ocular chemokine gene expression and leukocyte infiltration after high-risk corneal transplantation. , 2005, Molecular vision.
[47] J. Scheerlinck,et al. Prolongation of Sheep Corneal Allograft Survival by Transfer of the Gene Encoding Ovine IL-12-p40 but Not IL-4 to Donor Corneal Endothelium1 , 2005, The Journal of Immunology.
[48] M. Dana,et al. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium. , 2005, Investigative ophthalmology & visual science.
[49] K. Maruyama,et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. , 2004, Investigative ophthalmology & visual science.
[50] Jingtai Cao,et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. , 2004, The Journal of clinical investigation.
[51] M. Kuwano,et al. Induction of macrophage inflammatory protein-1α and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea , 2004, Angiogenesis.
[52] S. Yoshida,et al. Involvement of Macrophage Chemotactic Protein-1 and Interleukin-1β During Inflammatory but Not Basic Fibroblast Growth Factor–Dependent Neovascularization in the Mouse Cornea , 2003, Laboratory Investigation.
[53] F. Kruse,et al. High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. , 2003, Archives of ophthalmology.
[54] Claus Cursiefen,et al. Corneal Lymphangiogenesis: Evidence, Mechanisms, and Implications for Corneal Transplant Immunology , 2003, Cornea.
[55] H. Iwasaki,et al. Monocyte Chemoattractant Protein-1 Selectively Inhibits the Acquisition of CD40 Ligand-Dependent IL-12-Producing Capacity of Monocyte-Derived Dendritic Cells and Modulates Th1 Immune Response1 , 2002, The Journal of Immunology.
[56] F. Thaiss,et al. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells. , 2002, Kidney international.
[57] 小川 聡一郎. Induction of macrophage inflammatory protein-1α and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea , 2002 .
[58] H. Ochi,et al. Concentrations of serum granulocyte-colony-stimulating factor in normal pregnancy and preeclampsia. , 1999, Hypertension in pregnancy.
[59] D. Carbone,et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. , 1998, Journal of immunology.
[60] M. T. Tran,et al. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells. Beta-chemokine synthesis in corneal cells. , 1996, Investigative ophthalmology & visual science.
[61] S. Soker,et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. , 1995, Cancer research.
[62] J. Streilein,et al. ORTHOTOPIC CORNEAL TRANSPLANTATION IN MICE—EVIDENCE THAT THE IMMUNOGENETIC RULES OF REJECTION DO NOT APPLY , 1992, Transplantation.